Development and characterization of nanostructured lipid carriers of oral hypoglycemic agent: Selection of surfactants

International Journal of Pharmaceutical Sciences Review and Research

Volumn 7, Issue 2, 2011, Pages 125-130

  Jain, Nitin Kumar ^a   Ram, Alpana ^a  

^a GURU GHASIDAS UNIVERSITY   (India)

Author keywords

Glipizide; Nanostructured lipid carriers; Solvent diffusion method; Surfactants

Indexed keywords

GLIPIZIDE; GLYCEROL BEHENATE; NANOCARRIER; OLEIC ACID; PHOSPHATIDYLCHOLINE; POLOXAMER; TAUROCHOLIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; IN VITRO STUDY; NANOFABRICATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

EID: 79955564252     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Pardeike J, Hommoss A, Müller RH, Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products, Int J Pharm, 366, 2009, 170-184.
2. Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mader K, Investigations on the structure of solid lipid nanoparticles (SLN) and oil loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy, J Control Release 95, 2004, 217-227.
3. Müller RH, Radtke M, Wissing SA, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations, Adv Drug Deliver Rev, 54 Suppl. 1, 2002, S131-S155.
4. Sharma P, Ganta S, Denny WA, and Garg S, Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil, Int J Pharm, 367(1-2), 2009, 187-194.
5. Shivakumar HN, Patel PB, Desai BG, Ashok P, Arulmozhi S, Design and statistical optimization of glipizide loaded lipospheres using response surface methodology, Acta Pharm, 57, 2007, 269-285.
6. Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S, Preparation and characteristics of monostearin nanostructured lipid carriers, Int J Pharm 314, 2006, 83-89.
7. Zhang X, Liu J, Qiao H, Liu H, Ni J, Zhang W, Shi Y, Formulation optimization of dihydroartemisinin nanostructured lipid carrier usingresponse surface methodology, Powder Technol, 197, 2010, 120-128.
8. Zhang L, Liu L, Qian Y, Chen Y, The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM), Eur J Pharm Biopharm, 69, 2008 750-759.
9. Kim BD, Na K, Choi HK, Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan, Eur J Pharm Sci, 24, 2005, 199-205.
10. Martini S, Herrera ML, Physical properties of shortenings with low-trans fatty acids as affected by emulsifiers and storage conditions, Eur J Lipid Sci Technol, 110, 2008, 172-182.
11. Han F, Li S, Yin R, Liu H, Xu L, Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers, Colloid Surfaces A, 315, 2008, 210-216.
12. Komatsu H, Kitajima A, Okada S, Pharmaceutical characterization of commercially available intravenous fat emulsions: estimation of average particle size, size distribution and surface potential using photon correlation spectroscopy, Chem Pharm Bull, 43, 1995, 1412-1415.
13. Müller RH, Mader K, Gohla S, Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art, Eur J Pharm Biopharm, 50, 2000, 161-177.
14. Müller RH, Jacobs C, and Kayser O, Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future, Adv Drug Deliver Rev, 2001, 47, 3-19.
15. Souto EB, Wissing SA, Barbosa CM, Müller RH, Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery, Int J Pharm, 278, 2004, 71-77.
16. Jenning V, Thunemann AF, Gohla SH, Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquidand solid lipids, Int J Pharm, 199, 2000, 167-177.
17. Jenning V, Gohla SH, Encapsulation of retinoids in solid lipid nanoparticles (SLN), J Microencapsul, 18, 2001, 149-158.
18. Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S, Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system, Colloid Surface B, 45, 2005, 167-173.
19. Trotta Michele, Debernardi Francesca and Caputo Otto, Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique, Int J Pharm, 257, 2003, 153-160.
20. Liu M, Dong J, Yang Y, Yang X, Xu H, Characterization and release of triptolide-loaded poly (d, l-lactic acid) nanoparticles, Eur Polym J, 41, 2005, 375-382.
21. Doktorovová S, Araújo J, Garcia ML, Rakovský E and Souto EB, Formulating fluticasone propionate in novel PEGcontaining nanostructured lipidcarriers (PEG-NLC), Colloids Surface B, 75(2), 2010, 538-542.
22. Bunjes H, Westesen K, Influences of colloidal state on physical properties of solid fats, in: N Garti, K Sato (Eds), Processes in Fats and Lipid Systems, Marcel Dekker, Inc., New York, 2001, 457-483 & 177-210.
23. Teeranachaideekul V, Muller RH, Junyaprasert VB, Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-Effects of formulation parameters on physicochemical stability, Int J Pharm, 340, 2007, 198-206.
24. Teeranachaideekul V, Boonme P, Souto EB, Müller RH, Junyaprasert VB, Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC, J Control Release, 128, 2008, 134-141.
25. Lv Q, Yu A, Xi Y, Li H, Song Z, Cui Jing, Cao F, Zhai G, Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery, Int J Pharm, 372, 2009, 191-198.
26. Venkateswarlu V, Manjunath K, Preparation characterization and in vitro release kinetics of clozapine solid lipid nanoparticles, J Control Release, 95, 2004, 627-638.
27. Corrigan DO, Healy AM, Corrigan OI, The effect of spray drying solutions of bendroflumethiazide/polyethylene glycol on the physicochemical properties of the resultant materials, Int J Pharm; 262, 2003, 125-137.
28. Morissettea SL, Almarsson O, Peterson ML, Remenar JF, Read MJ, Lemmo AV, Ellis S, Cima MJ, Colin R, Highthroughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids, Adv Drug Deliver Rev; 56, 2004, 275-300.